Overview

A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

Status:
Withdrawn

Trial end date:
2022-12-31

Target enrollment:

Participant gender:

Summary

Compare the efficacy of adjuvant chemotherapy with Cisplatin or Carboplatin and Gemcitabine versus Gemcitabine in patients with resected or ablated intra-hepatic cholangiocarcinoma.

Phase:

Phase 3

Details

Lead Sponsor:

University of Louisville

Treatments:

Carboplatin
Cisplatin
Gemcitabine